[by 안전 바카라사이트, In Hyo] HK inno.N has initiated full-scale Phase 3 clinical trials for its obesity treatment candidate. The company announced on May 8 that it received approval from the Ministry of Food and Drug Safety on May 7 for the domestic Phase 3 investigational new drug (IND) clinical trial for ‘IN
[by 안전 바카라사이트, In Hyo] SillaJen reported on May 8 that two research findings on its anticancer drug candidate ‘BAL0891,’ currently under development, have been selected for presentation at the European Hematology Association (EHA) 2025 conference, scheduled to take place in Milan, Italy, from June 12 to
[by 안전 바카라사이트, Suin] With the global pharmaceutical and biotech investment landscape undergoing rapid transformation, there is growing recognition of the need for proactive strategies in intellectual property (IP) protection and milestone design to facilitate safer and more innovative cross-border technolo
[by Sung, Jae 안전 바카라사이트] Hugel, on May 8, posted KRW89.8 billion, KRW39.0 billion, and KRW30.9 billion for the first quarter net sales, operating profit, and net profit, respectively, based on a consolidated financial statement. With the highest-ever first-quarter earnings for the company, the figures rep
[by Lee, Young Sung] GI Biome, an affiliate of GI Innovation, announced on May 8 that it has received approval from the Ministry of Food and Drug Safety for the Phase 2a clinical trial (IND) of its microbiome-based therapeutic candidate, ‘GB-X01.’GB-X01 is a microbiome-based novel drug candidate con
[by 안전 바카라사이트, In Hyo] Humedix announced on May 8 that the company will acquire treasury stock worth 5 billion Korean won and transfer capital reserves to retained earnings. The company filed its disclosures on Korea's electronic disclosure system (DART) on May 7.The company acquired treasury stock worth
[by 안전 바카라사이트, Suin] “In the next two to three years, AI may reach a point where it can effectively replace R&D personnel, potentially outperforming human researchers in certain fields.”This statement was made by Alex Zhavoronkov, founder and CEO of Insilico Medicine (hereinafter referred to as Insilico),
[더바이오 유수인 기자] “앞으로 2~3년 안에 인공지능(AI)이 연구개발(R&D) 인력을 대체할 수 있을 것이라고 생각합니다. 어떤 분야에서는 AI를 쓰는 것이 더 나을 수도 있습니다.”알렉스 자보론코프(Alex Zhavoronkov) 인실리코메디신(Insilico Medicine, 이하 인실리코) 창업자 겸 최고경영자(CEO)는 7일 서울 삼성동 코엑스에서 열린 ‘바이오코리아 2025’ 현장에서 가진 인터뷰에서 이같이 말하며 AI 신약 개발 산업 현황을 진단했다.인실리코는 자체 개발 플랫폼인 ‘파마닷AI(Pharma.AI)’를
[by 안전 바카라사이트, In Hyo] Huons announced on May 7 that the company received FDA Abbreviated New Drug Application (ANDA) approvals for 1% (200 mg/20 mL) and 2% (400 mg/20 mL) multiple-dose vials for lidocaine hydrochloride injection on May 5th (local time).The approved multi-dose vials can be used multiple
[by Lee, Young Sung] LAMEDITECH, a healthcare and beauty device manufacturer specializing in laser technology, announced on May 7 that it has obtained medical device certification (TFDA) from the Ministry of Health and Welfare (MoHW) in Taiwan for its laser lancing device HandyRay series.The HandyRa
[by 안전 바카라사이트, Yong Jun] Celltrion’s antibody-drug conjugate (ADC) anticancer candidate, ‘CT-P70 (development code),’ is entering clinical trials for the first time in Korea.On May 2, the Ministry of Food and Drug Safety approved Celltrion’s investigational new drug (IND) application for the Phase 1 clinic
[by 안전 바카라사이트, Yong Jun] Dt&CRO announced on May 7 that it is providing global-standard services by leveraging a standardized efficacy evaluation system and advanced analysis capabilities, under the leadership of a study director with extensive expertise in non-clinical ophthalmic disease research.The comp
[by Sung, Jae 안전 바카라사이트] SK bioscience announced on May 7 that it has been selected for the Korea Disease Control and Prevention Agency (KDCA)’s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Program.This government-led initiative aims to develop vaccines against avian influenza—ident
[by 안전 바카라사이트, In Hyo] Lunit, a medical AI company, announced on May 7 a strategic partnership with Starvision Service GmbH, Germany’s largest private radiology network. Through a newly signed framework agreement, Lunit’s AI imaging solutions will be deployed across Starvision’s expansive network of radi
[by 안전 바카라사이트, Suin] Chairman Seo Jung-jin of Celltrion held a meeting with Donald Trump Jr., the eldest son of U.S. President Donald Trump, during his visit to Korea. Among pharmaceutical industry representatives, Seo was the sole participant granted the opportunity for a ‘relay interview.’ In light of hi
[by 안전 바카라사이트, Yong Jun] STCube revealed on April 30 that it presented its next-generation immunotherapy treatment strategy and corresponding clinical research findings targeting the ‘BTN1A1-YAP1’ axis at the ‘American Association for Cancer Research Annual Meeting (AACR 2025),’ held in Chicago, USA.The co
[by 안전 바카라사이트, Yong Jun] Huons announced on May 2 that its preliminary earnings for the first quarter of this year were reported as consolidated sales of 145.8 billion KRW, operating profit of 12.8 billion KRW, and net profit of 12.4 billion KRW, reflecting year-on-year changes of -1.3%, +20.1%, and +26.4%
[by 안전 바카라사이트, Suin] Huons Group announced the spin-off of its health functional food business and its merger with subsidiary Huons Foodience on May 2. The company officially launched Huons N to consolidate the group’s strategic capabilities in health functional food and drive full-scale growth.By merging
[by 안전 바카라사이트, Suin] Abion revealed on April 29 the preclinical data on its TROP2-targeting antibody-interferon beta fusion protein, ‘ABN202,’ at the American Association for Cancer Research (AACR), highlighting its superior anticancer efficacy compared to existing commercialized antibody-drug conjugates (
[by 안전 바카라사이트, Yong Jun] CHA Medical Center of CHA University announced on April 29 that it has become the first infertility center in Korea to enter the Japanese market by affiliating with ‘HART Clinic,’ a major infertility treatment center in Japan that treats approximately 1,200 infertile patients annua
